These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16499255)

  • 1. A community-based TB drug susceptibility study in Mimika District, Papua Province, Indonesia.
    Kelly PM; Ardian M; Waramori G; Anstey NM; Syahrial H; Tjitra E; Bastian I; Maguire GP; Lumb R
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):167-71. PubMed ID: 16499255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Mycobacterium tuberculosis isolates from treatment failure patients living in East Timor.
    Kelly PM; Lumb R; Pinto A; da Costa G; Sarmento J; Bastian I
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):81-6. PubMed ID: 15675555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-resistant tuberculosis in Yangon, Myanmar.
    Phyu S; Lwin T; Ti T; Maung W; Mar WW; Shein SS; Grewal HM
    Scand J Infect Dis; 2005; 37(11-12):846-51. PubMed ID: 16308219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis in east timorese refugees: implications for health care needs in East Timor.
    Kelly PM; Scott L; Krause VL
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):980-7. PubMed ID: 12475144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
    Abate G; Miörner H; Ahmed O; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China].
    Shen X; Li J; Gao Q; Xu B; Mei J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan.
    Javaid A; Hasan R; Zafar A; Ghafoor A; Pathan AJ; Rab A; Sadiq A; Akram CM; Burki I; Shah K; Ansari M; Rizvi N; Khan SU; Awan SR; Syed ZA; Iqbal ZH; Shaheen Z; ur Rehman N
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):326-31. PubMed ID: 18284840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.
    Mendoza MT; Gonzaga AJ; Roa C; Velmonte MA; Jorge M; Montoya JC; Tan Torres T; Ong M; Barez MY; Ang CF
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):59-63. PubMed ID: 9441060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of drug-resistant tuberculosis in an HIV endemic area in northern Thailand.
    Yoshiyama T; Supawitkul S; Kunyanone N; Riengthong D; Yanai H; Abe C; Ishikawa N; Akarasewi P; Payanandana V; Mori T
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):32-9. PubMed ID: 11263513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of acquired MDR-TB and HIV co-infection.
    Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R
    Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
    Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.